Systemic Disorders. Are They Relevant for Oral Health?

Presented by: Dr. José Lança

RCDSO Expiry Date: August 31, 2025

To qualify as a Core Category 1 course, the course certificate must be issued no later than this date.

RCDSO CE Points: 3, Category 1

Click to close
  • Dr. José Lança MD, PhD

    Assistant Professor of Pharmacology in the Faculty of Dentistry and the Temerty Faculty of Medicine

    Dr. José Lança, MD, PhD is an Assistant Professor of Pharmacology in the Faculty of Dentistry and the Temerty Faculty of Medicine, University of Toronto (UofT). He is also affiliated with the School of Graduate Studies and Centre for the Study of Pain at the UofT. He is also affiliated with the School of Graduate Studies and Centre for the Study of Pain at the U of T. He is a member of several professional organizations, including the American College of Clinical Pharmacology, Society for Neuroscience, and the American Society for Pharmacology and Experimental Therapeutics.

    Dr. Lança has contributed extensively to curriculum development and teaching of pharmacology, therapeutics and interprofessional education.He is the director of several undergraduate and graduate courses in the Faculty of Dentistry and has been the Undergraduate Program Director in the Department of Pharmacology and Toxicology, Faculty of Medicine. He has developed and taught courses and seminars in Continuing Medical and Dental Education, including the American Medical Association, Canadian Dental Association, amongst others.

Current Status
Not Enrolled
Price
$50
Get Started

The relevance of systemic diseases and implications on oral health is well established. However, the effects of medications used in the management of systemic disorders on oral health are often overlooked. In this presentation Dr. Lanca discusses the selective pathologies with high prevalence, as well as the effects of the medications used in the pharmacotherapy of those patients and importance for clinical practice.

The following systemic disorders and therapies are discussed:

  1. Asthma and Chronic Obstructive Pulmonary Disease;
  2. Hypertension;
  3. Anticoagulation;
  4. Diabetes;
  5. Epilepsy; and
  6. Parkinson’s Disease.

Learning Objectives:

The goals of this presentation are:

  • Present an up to date overview of these disorders;
  • Discuss the mechanisms of action of medications commonly used in their treatment (e.g., bronchodilators, antihypertensives, anticoagulants, antidiabetics, antiepileptic and antiparkinsonian medications);
  • Discuss the adverse effects of pharmacotherapy on oral health (e.g., non-odontogenic tooth pain, periodontitis, thrombocytopenia and bleeding, hypoglycemia, gingival hyperplasia and behavioural dysfunction); and
  • Discuss prevention and management of those adverse effects on oral health.